Drugs / Egyptian MTA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06683833 | Sep 2025 → May 2026 overdue | dental caries | Cairo University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Egyptian MTA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06683833 ↗ |
| Known as | MTA | “The liquid of Egyptian MTA (Toothmate) will be mixed with powder according to the manufacturers' instructions.” NCT06683833 ↗ |
| Known as | Toothmate | “The liquid of Egyptian MTA (Toothmate) will be mixed with powder according to the manufacturers' instructions.” NCT06683833 ↗ |